Giulia Cheloni, B.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Stem Cells | 9 | 2020 | 1376 | 1.500 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2020 | 689 | 1.310 |
Why?
|
Acriflavine | 1 | 2017 | 6 | 0.620 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2017 | 198 | 0.560 |
Why?
|
Cell Hypoxia | 1 | 2019 | 675 | 0.550 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 730 | 0.440 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1276 | 0.430 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2021 | 3523 | 0.380 |
Why?
|
Leukemia | 1 | 2019 | 1511 | 0.370 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 236 | 0.330 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2219 | 0.270 |
Why?
|
K562 Cells | 2 | 2017 | 634 | 0.250 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3703 | 0.250 |
Why?
|
Macrolides | 2 | 2016 | 201 | 0.240 |
Why?
|
Cancer Vaccines | 2 | 2022 | 1023 | 0.240 |
Why?
|
Stem Cell Niche | 2 | 2019 | 346 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2016 | 5172 | 0.210 |
Why?
|
Fusion Proteins, bcr-abl | 4 | 2016 | 434 | 0.180 |
Why?
|
Pyridazines | 1 | 2020 | 202 | 0.170 |
Why?
|
Oxygen | 4 | 2019 | 4189 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.160 |
Why?
|
Histones | 2 | 2021 | 2599 | 0.150 |
Why?
|
Tretinoin | 1 | 2019 | 517 | 0.140 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 677 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5442 | 0.130 |
Why?
|
Multiple Myeloma | 2 | 2023 | 5181 | 0.130 |
Why?
|
Imidazoles | 1 | 2020 | 1206 | 0.120 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2014 | 85 | 0.120 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 871 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11524 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1526 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 2957 | 0.090 |
Why?
|
Valproic Acid | 1 | 2013 | 445 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2013 | 494 | 0.090 |
Why?
|
Chromatin | 1 | 2021 | 2934 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1678 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1897 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.080 |
Why?
|
Dendritic Cells | 3 | 2023 | 2725 | 0.070 |
Why?
|
Cell Survival | 1 | 2017 | 5882 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7301 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4397 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3386 | 0.070 |
Why?
|
Transcription Factors | 3 | 2021 | 12208 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5256 | 0.060 |
Why?
|
Mice | 7 | 2022 | 81183 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2019 | 16689 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12072 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9648 | 0.050 |
Why?
|
Humans | 18 | 2023 | 744343 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2016 | 651 | 0.050 |
Why?
|
Animals | 8 | 2022 | 168757 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 903 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 21827 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 51 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 268 | 0.040 |
Why?
|
Tumor Stem Cell Assay | 1 | 2018 | 118 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2023 | 2124 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 321 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 930 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2018 | 10481 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2018 | 657 | 0.040 |
Why?
|
Dexamethasone | 1 | 2023 | 1951 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 809 | 0.030 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2014 | 94 | 0.030 |
Why?
|
Cell Count | 1 | 2018 | 1856 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1117 | 0.030 |
Why?
|
Apoptosis | 3 | 2015 | 9727 | 0.030 |
Why?
|
Fluorenes | 1 | 2014 | 160 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2437 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1988 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13695 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1708 | 0.030 |
Why?
|
P-Selectin | 1 | 2014 | 600 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2022 | 5524 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5535 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5892 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 345 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3586 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1085 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3505 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8324 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1632 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.020 |
Why?
|
Lysine | 1 | 2013 | 1007 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2967 | 0.020 |
Why?
|
DNA Damage | 1 | 2015 | 2432 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2019 | 14557 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10180 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8428 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4554 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18029 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
Aged | 2 | 2020 | 163280 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 213383 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11483 | 0.010 |
Why?
|
Adult | 2 | 2020 | 214055 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23403 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40075 | 0.010 |
Why?
|
Male | 1 | 2020 | 350118 | 0.000 |
Why?
|
Female | 1 | 2020 | 380194 | 0.000 |
Why?
|